HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Maury Selected Research

E Maury Research Topics

Disease

3Critical Illness (Critically Ill)
01/2019 - 12/2007
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2014 - 09/2007
3Inflammation (Inflammations)
11/2014 - 07/2003
3Septic Shock (Toxic Shock Syndrome)
07/2014 - 05/2011
3Obesity
06/2013 - 09/2007
2Type 2 Diabetes Mellitus (MODY)
03/2015 - 09/2014
2acquired Thrombotic thrombocytopenic purpura
02/2015 - 01/2006
2Thrombotic Thrombocytopenic Purpura
02/2015 - 01/2006
2Cardiovascular Diseases (Cardiovascular Disease)
11/2014 - 01/2010
2Shock
07/2014 - 12/2001
2Sepsis (Septicemia)
08/2010 - 02/2008
1Clear Cell Adenocarcinoma
01/2020
1Osteoarthritis
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2019
1Paralysis (Palsy)
01/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017
1Diabetes Complications
01/2017
1Peripheral Nervous System Diseases (PNS Diseases)
01/2017
1Pain (Aches)
01/2017
1Hemorrhage
11/2015
1Chronic Renal Insufficiency
03/2015
1Thrombotic Microangiopathies
02/2015
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2014
1Oliguria
05/2011
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
12/2003
1Erythema
03/2003
1Infections
03/2003
1Phlebitis
03/2003
1Pneumothorax
08/2001
1Respiratory Sounds (Crackle)
10/2000
1Infarction (Infarctions)
06/2000
1Colitis
05/2000

Drug/Important Bio-Agent (IBA)

3AdipokinesIBA
06/2013 - 09/2007
2Advanced Glycation End ProductsIBA
01/2017 - 03/2015
2thiamine triphosphorate (TTP)IBA
02/2015 - 01/2006
2LipidsIBA
11/2014 - 07/2003
1Carbon DioxideIBA
01/2019
1Syntex adjuvant formulationIBA
01/2017
1Heparin (Liquaemin)FDA LinkGeneric
11/2015
1AnticoagulantsIBA
11/2015
1Troponin IIBA
02/2015
1Glucose (Dextrose)FDA LinkGeneric
11/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
09/2014
1Insulin (Novolin)FDA Link
09/2014
1EndocannabinoidsIBA
06/2013
1Lactic Acid (Lactate)FDA LinkGeneric
05/2011
1cyclo(Arg-Pro) (CI 4)IBA
05/2011
1Antifibrinolytic Agents (Antifibrinolytics)IBA
08/2010
1Blood Proteins (Serum Proteins)IBA
02/2008
1HES 130-0.4IBA
02/2008
1Serum AlbuminIBA
02/2008
1Starch (Cornstarch)IBA
02/2008
1CarcinogensIBA
09/2007
1Thrombopoietin (c-mpl Ligand)IBA
09/2007
1CytokinesIBA
09/2007
1InterleukinsIBA
09/2007
1ChemokinesIBA
09/2007
1Chemokine CCL5IBA
09/2007
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
09/2007
1Tissue Inhibitor of MetalloproteinasesIBA
09/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2007
1AntibodiesIBA
01/2006
1Dihydropteroate Synthase (Dihydropteroate Synthetase)IBA
12/2003
1EicosanoidsIBA
07/2003
1Phospholipases A2 (Phospholipase A2)IBA
07/2003
1Polyvinyl Chloride (PVC)IBA
03/2003
1Digoxin (Digitek)FDA LinkGeneric
06/2000
1Fusidic Acid (Fucithalmic)IBA
05/2000

Therapy/Procedure

4Resuscitation
11/2015 - 05/2011
3Therapeutics
11/2015 - 12/2007
1Operative Surgical Procedures
01/2020
1Nephrectomy
01/2020
1Critical Care (Surgical Intensive Care)
01/2019
1Sutures (Suture)
01/2019
1Subcutaneous Injections
11/2015
1Anticoagulation Reversal
11/2015
1Extracorporeal Membrane Oxygenation
10/2014
1Fluid Therapy (Oral Rehydration Therapy)
02/2008
1Artificial Respiration (Mechanical Ventilation)
12/2001
1Central Venous Catheters
08/2001
1Catheters
08/2001
1Mechanical Ventilators (Ventilator)
10/2000
1Oral Administration
05/2000